Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFSAN

This article was originally published in The Tan Sheet

Executive Summary

Ephedra strategy, dietary supplement labeling guide and research plan made "B" list priorities for 2001, foods center says in mid-year accomplishments paper issued July 10. Actions are not expected to be completed by end of FY 2001, as originally proposed (1"The Tan Sheet" Jan. 15, p. 3). Urgent matters such as BSE, food allergens, genetically modified corn forced CFSAN to reframe priorities for fiscal year, center explains

You may also be interested in...



GMPs, Food Safety, Industry Guidances Among CFSAN’s 2002 Top Priorities

Industry guidances on dietary supplement regulations and labeling issues are slated to be released by FDA's Center for Food Safety & Applied Nutrition over the next two years

GMPs, Food Safety, Industry Guidances Among CFSAN’s 2002 Top Priorities

Industry guidances on dietary supplement regulations and labeling issues are slated to be released by FDA's Center for Food Safety & Applied Nutrition over the next two years

GMPs, Food Safety, Industry Guidances Among CFSAN’s 2002 Top Priorities

Industry guidances on dietary supplement regulations and labeling issues are slated to be released by FDA's Center for Food Safety & Applied Nutrition over the next two years

Topics

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel